| Caméléna F. et al.
Detection of Klebsiella pneumoniae isolates coproducing the plasmid-encoded 16S rRNA methyltransferase RmtF and carbapenemase in Paris, France.
Int. J. Antimicrob. Agents 2022 Sep
| Marlin R. et al.
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
Nat. Commun. 2022 Aug 30
| Sibiude J. et al.
Update of perinatal HIV-1 transmission in France: zero transmission for 5482 mothers on continuous ART from conception and with undetectable viral load at delivery.
Clin. Infect. Dis. 2022 Aug 29
| Mailhe M. et al.
Clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection: an observational cohort study.
Clin. Microbiol. Infect. 2022 Aug 23
| Hobson CA. et al.
Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime-avibactam: an evolutionary overview.
Antimicrob. Agents Chemother. 2022 Aug 18
| Ferré VM. et al.
Detection of monkeypox virus in anorectal swabs from asymptomatic men who Have sex with men in a sexually transmitted infection screening program in Paris, France.
Ann. Intern. Med. 2022 Aug 16
| Marin J. et al.
The population genomics of increased virulence and antibiotic resistance in human commensal Escherichia coli over 30 years in France.
Appl. Environ. Microbiol. 2022 Aug 9
| Billard-Pomares T. et al.
Use of whole-genome sequencing to explore Mycobacterium tuberculosis complex circulating in a hotspot department in France.
Microorganisms. 2022 Aug 6
| Vigué L. et al.
Deciphering polymorphism in 61,157 Escherichia coli genomes via epistatic sequence landscapes.
Nat. Commun. 2022 Jul 12
| Walter T. et al.
Extended prone positioning duration for COVID-19-related ARDS: benefits and detriments.
Crit. Care 2022 Jul 8
| Habib A. et al.
Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan.
PLoS One 2022 Jul 8
| Hobson CA. et al.
MiniBioReactor Array (MBRA) in vitro gut model: a reliable system to study microbiota-dependent response to antibiotic treatment.
JAC Antimicrob. Resist. 2022 Jul 5
| Belan M. et al.
SARS-CoV-2 Exposures of Healthcare Workers from Primary Care, Long-Term Care Facilities and Hospitals: A Nationwide Matched Case-Control Study.
Clin. Microbiol. Infect. 2022 Jun 28
| Danjean M. et al.
Evaluation of the inoculum effect of new antibiotics against carbapenem-resistant Enterobacterales.
Clin. Microbiol. Infect. 2022 Jun 28
| Claessens YE. et al.
Early chest CT-scan in emergency patients affected by community-acquired pneumonia is associated with improved diagnosis consistency.
Eur. J. Emerg. Med. 2022 Jun 28
| Molina JM. et al.
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
Lancet HIV. 2022 Jun 27
| Rybak A.et al.
A 16 th century Escherichia coli draft genome associated with an opportunistic bile infection.
Commun. Biol. 2022 Jun 16
| Rybak A.et al.
Reassessing the Performance of the « Step-By-Step » Approach to Febrile Infants 90 Days of Age and Younger in the Context of the COVID-19 Pandemic: A Multicentric Retrospective Study.
Pediatr. Infect. Dis. J. 2022 Jun 15
| Martin-Blondel G. et al.
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study.
BMC Infect Dis. 2022 Jun 13
| Ader F. et al.
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
Lancet Infect. Dis. 2022 Jun 1
| Moussiegt A. et al.
Escherichia coli community-acquired meningitis in adults: a case series of 29 patients in France.
Clin. Microbiol. Infect. 2022 May 11
| Tesson F.et al.
Systematic and quantitative view of the antiviral arsenal of prokaryotes.
Nat. Commun. 2022 May 2
| d’Humières C.et al.
Contribution of Clinical Metagenomics to the Diagnosis of Bone and Joint Infections.
Front. Microbiol. 2022 Apr 21
| Ghazali DA.et al.
The Response of Emergency Departments (EDs) to the COVID-19 Pandemic: The Experience of 5 EDs in a Paris-Based Academic Hospital Trust.
Qual. Manag. Health Care. 2022 Apr 4
| Su WL.et al.
TisB Protein Protects Escherichia coli Cells Suffering Massive DNA Damage from Environmental Toxic Compounds.
mBio. 2022 Apr 2
| Hobson CA.et al.
The interplay between anticancer challenges and the microbial communities from the gut.
Eur. J. Clin. Microbiol. Infect. Dis. 2022 Mar 30
| Contejean A.et al.
Antimicrobial stewardship in high-risk febrile neutropenia patients.
Antimicrob. Resist. Infect. Control. 2022 Mar 26
| Denamur E.et al.
Genome wide association study of Escherichia coli bloodstream infection isolates identifies genetic determinants for the portal of entry but not fatal outcome.
PLoS Genet. 2022 Mar 24
| Rossi G.et al.
Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses.
Infection. 2022 Mar 22
| Lo S.et al.
Simultaneous Hospital Outbreaks of New Delhi Metallo-β-Lactamase-Producing Enterobacterales Unraveled Using Whole-Genome Sequencing.
Microbiol. Spectr. 2022 Mar 21
| Le Hingrat Q.et al.
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates.
AIDS. 2022 Mar 8
| Moby V.et al.
Poor oral health and hygiene habits in patients with infective endocarditis and previously identified predisposing cardiac condition: A prospective cohort study.
J. Infect. 2022 Mar 2
| Lingas G.et al.
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial.
J. Antimicrob. Chemother. 2022 Mar 2
| Congo-Ouedraogo M.et al.
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018-2019.
J. Eur. Acad. Dermatol. Venereol. 2022 Feb 28
| Royer G. et al.
Reduced chlorhexidine susceptibility is associated with tetracycline resistance tet genes in clinical isolates of Escherichia coli.
Antimicrob. Agents Chemother. 2022 Feb 28
| Berthod D. et al.
Are there reasons behind high Handrub consumption? A French National in-depth qualitative assessment.
Antimicrob. Resist. Infect. Control. 2022 Feb 23
| Leducq V. et al.
Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020.
Sci. Rep. 2022 Feb 20
| Timsit J.F. et al.
Cefiderocol for the Treatment of Infections Due To Metallo-Beta-Lactamase-Producing Pathogens in the CREDIBLE-CR And APEKS-NP Phase 3 Randomized Studies.
Clin. Infect. Dis. 2022 Feb 11
| Egloff C. et al.
Pregnant women’s perceptions of the COVID-19 vaccine: A French survey.
PLoS One 2022 Feb 7
| Landman R. et al.
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.
Lancet HIV. 2022 Feb 1
| Guyeux C. et al.
Connection between two historical tuberculosis outbreak sites in Japan, Honshu, by a new ancestral Mycobacterium tuberculosis L2 sublineage.
Epidemiol. Infect. 2022 Jan 19
| de Lastours V. et al.
Evolution of fluoroquinolone-resistant Escherichia coli in the gut after ciprofloxacin treatment.
Int. J. Med. Microbiol. 2022 Jan 4
| Choudhury A. et al.
High-throughput navigation of the sequence space.
New Front. and Appl. of Synth. Biology. 2022 Jan